Edgewise Therapeutics, Inc. EWTX
- EDG-15400 — Heart Failure with Preserved Ejection Fraction Phase 2
- EDG-7500 — Obstructive Hypertrophic Cardiomyopathy Phase 2
- EDG-7500 — Non-Obstructive Hypertrophic Cardiomyopathy Phase 2
Home › Targets › cardiac sarcomere
cardiac sarcomere (1 companies · 3 programs)
Companies with an active program directed at cardiac sarcomere.